PTC Therapeutics
PTCT
$28.32
Share price
11.10%
Change (1 day)
-44.69%
Change (1 year)
Categories
Earnings for PTC Therapeutics (PTCT)
Earnings in 2023 (TTM): -$0.7 B
According to PTC Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.7 B. In 2022 the company made an earning of -$0.59 B a decrease over its 2021 earnings that were of -$0.52 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for PTC Therapeutics from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.7 B | 18.49% |
| 2022 | -$0.59 B | 13.34% |
| 2021 | -$0.52 B | 28.64% |
| 2020 | -$0.41 B | 67.94% |
| 2019 | -$0.24 B | 87.28% |
| 2018 | -$0.13 B | 64.95% |
| 2017 | -$77.67 M | -45.13% |
| 2016 | -$0.15 B | -16.72% |
| 2015 | -$0.17 B | 72.64% |
| 2014 | -$98.45 M | 90.89% |
| 2013 | -$51.58 M | 96.58% |
| 2012 | -$26.24 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $9.43 B | -1,455.82% | 🇨🇭 Switzerland |
 Vertex Pharmaceuticals VRTX | $4.42 B | -735.52% | 🇺🇸 USA |
 Xencor XNCR | -$0.13 B | -82.70% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -$0.53 B | -25.29% | 🇺🇸 USA |
 Fate Therapeutics
FATE | -$0.2 B | -72.63% | 🇺🇸 USA |
 Avidity Biosciences RNA | -$0.22 B | -69.51% | 🇺🇸 USA |